Patient Characteristics and Presence of a Dominant T-Cell Clone Detected by GC Clamp Multiplex PCR-DGGE in Cutaneous Lesions
| Patient Characteristics . | No. of Patients . | No. of Patients With Cutaneous PCRγ(+) . |
|---|---|---|
| Total no. | 68 | 42 (62%) |
| Age at MF diagnosis (yr) | ||
| ≤65 | 43 | 27 (62%) |
| >65 | 25 | 15 (60%) |
| Sex | ||
| Male | 41 | 25 (61%) |
| Female | 27 | 17 (63%) |
| Duration of symptoms before MF diagnosis (mo) | ||
| <120 | 54 | 33 (61%) |
| ≥120 | 13 | 9 (69%) |
| Not determined | 1 | 0 |
| Type of cutaneous lesion | ||
| Patch/plaque (T1/T2) | 51 | 30 (59%) |
| Tumor | 8 | 8 (100%) |
| Erythroderma | 9 | 4 (44%) |
| TNM staging | ||
| IA | 19 | 11 (58%) |
| IB | 13 | 8 (62%) |
| IIA | 16 | 9 (56%) |
| IIB | 5 | 5 (100%) |
| III | 6 | 3 (50%) |
| IV | 9 | 6 (67%) |
| Patient Characteristics . | No. of Patients . | No. of Patients With Cutaneous PCRγ(+) . |
|---|---|---|
| Total no. | 68 | 42 (62%) |
| Age at MF diagnosis (yr) | ||
| ≤65 | 43 | 27 (62%) |
| >65 | 25 | 15 (60%) |
| Sex | ||
| Male | 41 | 25 (61%) |
| Female | 27 | 17 (63%) |
| Duration of symptoms before MF diagnosis (mo) | ||
| <120 | 54 | 33 (61%) |
| ≥120 | 13 | 9 (69%) |
| Not determined | 1 | 0 |
| Type of cutaneous lesion | ||
| Patch/plaque (T1/T2) | 51 | 30 (59%) |
| Tumor | 8 | 8 (100%) |
| Erythroderma | 9 | 4 (44%) |
| TNM staging | ||
| IA | 19 | 11 (58%) |
| IB | 13 | 8 (62%) |
| IIA | 16 | 9 (56%) |
| IIB | 5 | 5 (100%) |
| III | 6 | 3 (50%) |
| IV | 9 | 6 (67%) |